Class Notes (1,100,000)
CA (620,000)
UTSG (50,000)
HMB265H1 (200)
Lecture

Notes taken during lecture


Department
Human Biology
Course Code
HMB265H1
Professor
Stephen Wright

This preview shows half of the first page. to view the full 2 pages of the document.
LECTURE 24 April 7th, 2011
GENE THERAPY
Viable method to treat individuals with specific disease or disorder
Sequencing of human genome rschers thought will accelerate gene therapy
development
oNew information that came about in subsequent years and decades really
pinpointed or emphasized hat genes are not separate entities
oInteractions involved in cell and tissues are complex
oComplexity of interactions affect gene therapy methods
oProcedure can be harmful to patient
oCaused rschers to reevaluate gene therapy as method to treat disease
Somatic gene therapy
Better than just treating symptoms
Germ line gene therapy
oAlters DNA of gamete or of the embryo so all cells contain alteration
Can be passed down to offspring
Not yet possible in humans
oCan create transgenic animals, like flies
Other ytpe is somatic gene therapy
oNonheritable
oCorrects disease phenotype in somatic cells affected by disorder or disease
oTwo types
In vivo
Ex vivo
Differ in terms of invasiveness
In vivo functional gene and DNA vector being injected into say, the brain
oOr into artery to lead to liver
oVERY invasive
Ex vivo less invasive
oCells altered removed, therapeutic genes added, reinfused and returned
into patient intravenously
oMost commonly performed because less invasive
First human trials occurred two decades ago
Two girls
SCID caused by mutation in ADA gene
When have lack of ADA functional gene expression unable to mount proper
immune response
At cellular level, effect
oADA deficiency causes deoxy ATP to build up in cells
oLack of ADA blocks pathway important
www.notesolution.com
You're Reading a Preview

Unlock to view full version